Guardant Health (GH) Director Azar Converts 1,651 RSUs

What Happened

• Azar Alex M II, a director of Guardant Health (GH), had 1,651 restricted stock units (RSUs) convert/exercise into 1,651 common shares on September 12, 2026 (transaction code M). The reported acquisition price is $0.00 per share (RSUs have no exercise price), so the Form 4 shows $0 total value for the conversion.
• The filing also reports a simultaneous disposition of 1,651 shares (also at $0.00). The report does not state the reason for the disposition; filings like this commonly reflect share withholding for taxes when RSUs vest, though the Form 4 does not explicitly say that here.

Key Details

• Transaction date: 2026-09-12; Form 4 filed: 2026-09-14 (appears timely).
• Transaction type and code: Exercise/conversion of a derivative (M).
• Shares acquired: 1,651 at $0.00; shares disposed: 1,651 at $0.00.
• Footnotes: F1 — RSU award granted 2025-09-12, vests over four years with 25% vesting on 2026-09-12 (this vesting produced the shares). F2 — not applicable for RSUs.
• Shares owned after the transaction: not reported in the provided excerpt.

Context

• RSUs convert to shares without an exercise price, so conversions commonly show $0.00 acquisition price. When the same number of shares is reported as disposed, that often indicates shares were surrendered to cover taxes or withholding, but the Form 4 here does not specify the mechanism.
• This transaction is not a cash purchase (not a bullish purchase signal); it reflects routine vesting and conversion of previously granted RSUs.